New COVID-19 Omicron subvariant possesses ability to resist all therapeutic antibodies
According to a new study by researchers at the German Primate Center (DPZ) – Leibniz Institute for Primate Research and Friedrich-Alexander University Erlangen-Nürnberg, the COVID-19 Omicron subvariant BQ.1.1, is immune to all approved…